Work

281 Phase I study of intravenous (IV) CI-1033 in patients with advanced solid tumors

Year: 2004

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(04)80289-1

Authors: G. Simon, S. Olson, M. Langevin, I. Eiseman, J. Mahany, W. Helmke, C. Garrett, R. Lush, P. Lenehan, D. Sullivan

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2012498813

Cites:

Cited by: 1

Related to: 10